Original Article

Exploring Adenylate Kinase 8 (ADK8) of Echinococcus granulosus as a Novel Immunogen Against Cystic Echinococcosis: A Computational Perspective

Abstract

Background: Vaccination represents a promising strategy for preventing hydatidosis. We aimed to characterize the physicochemical properties of adenylate kinase 8 from Echinococcus granulosus (EgADK8) and identify potential B- and T-cell epitopes as vaccine candidates.
Methods: Multiple web-based servers were employed to predict immunogenic epitopes and evaluate the physicochemical, antigenic, structural, and subcellular characteristics of EgADK8.
Results: EgADK8 was predicted to be an extracellular protein with a molecular weight of 38.78 kDa. The protein showed no allergenic potential and exhibited high hydrophilicity, predicted thermal stability, and 36 potential post-translational modification sites. The secondary structure was mainly composed of alpha helices and random coils. The highest-quality three-dimensional model generated by the Robetta server achieved a confidence score of 0.79. Three independent prediction servers identified 16 linear and 9 conformational B-cell epitopes. Furthermore, two helper T lymphocyte (HTL) epitopes with predicted IFN-γ-inducing potential were identified after comprehensive screening. Additionally, five immunogenic human cytotoxic T lymphocyte (CTL) epitopes with predicted IFN-γ-inducing potential and three murine CTL epitopes were identified.
Conclusion: These findings provide preliminary computational evidence supporting further investigation of EgADK8 as a potential component of a multiepitope vaccine against CE. The main limitation of this study was its reliance on computational analyses. Therefore, experimental validation using the whole protein and/or selected epitopes, either individually or in combination with other antigens, is required.

1. Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century. Clinical Microbiol Rev. 2019;32(2):e00075-18.
2. Shams M, Javanmardi E, Nosrati MC, et al. Bioinformatics features and immunogenic epitopes of Echinococcus granulosus Myophilin as a promising target for vaccination against cystic echinococcosis. Infect Genet Evol. 2021;89:104714.
3. Khalkhali H, Foroutan M, Khademvatan S, et al. Prevalence of cystic echinococcosis in Iran: a systematic review and meta-analysis. J Helminthol. 2018;92(3):260-8.
4. McManus DP, Gray DJ, Zhang W, Yang YJB. Diagnosis, treatment, and management of echinococcosis. BMJ. 2012;344:e3866.
5. Budke CM, Carabin H, Ndimubanzi PC, et al. A systematic review of the literature on cystic echinococcosis frequency worldwide and its associated clinical manifestations. Am J Trop Med Hyg. 2013;88(6):1011-27.
6. Budke CM, Deplazes P, Torgerson PR. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis. 2006;12(2): 296-303.
7. Otero-Abad B, Torgerson PRJPNTD. A systematic review of the epidemiology of echinococcosis in domestic and wild animals. PLoS Negl Trop Dis. 2013;7(6):e2249.
8. Pourseif MM, Moghaddam G, Saeedi N, Barzegari A, Dehghani J, Omidi Y. Current status and future prospective of vaccine development against Echinococcus granulosus. Biologicals. 2018;51:1-11.
9. Mukherjee S, Mukherjee N, Gayen P, et al. Metabolic inhibitors as antiparasitic drugs: pharmacological, biochemical and molecular perspectives. Curr Drug Metab. 2016;17(10):937-70.
10. Lightowlers M, Colebrook A, Gauci C, et al. Vaccination against cestode parasites: anti-helminth vaccines that work and why. Vet Parasitol. 2003;115(2):83-123.
11. Vercruysse J, Knox DP, Schetters TP, Willadsen P. Veterinary parasitic vaccines: pitfalls and future directions. Trends Parasitol. 2004;20(10):488-92.
12. Craig P, Hegglin D, Lightowlers M, Torgerson PR, Wang Q. Echinococcosis: control and prevention. Adv Parasitol. 96:55-158.
13. Song H-Y, Zhan J-F, Hua R-Q, et al. Molecular characterization and immunological properties of Echinococcus granulosus sensu stricto (G1) ADK1 and ADK8. Parasitol Res. 2023;122(7):1557-65.
14. Das NC, Gorai S, Gupta PSS, et al. Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: A reverse vaccinology approach. Int Immunopharmacol. 2024;133:112120.
15. Kaur A, Kumar A, Kumari G, et al. Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory. Heliyon. 2024;10(16): e36154.
16. Padma S, Patra R, Sen Gupta PS, et al. Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach. Vaccines (Basel). 2023;11(3):525.
17. Das NC, Patra R, Gupta PSS, et al. Designing of a novel multi-epitope peptide based vaccine against Brugia malayi: An in silico approach. Infect Genet Evol. 2021;87:104633.
18. Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook: Springer; 2005. p. 571-607.
19. Safari N, Ardakan AK, Hamedi E, et al. An in silico approach to decipher immunogenic epitopes in Toxoplasma gondii GRA1 and GRA3. Informatics in Medicine Unlocked. 2024;44:101435.
20. Ponomarenko J, Bui H-H, Li W, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. 2008;9:514.
21. Majidiani H, Soltani S, Ghaffari AD, et al. In-depth computational analysis of calcium-dependent protein kinase 3 of Toxoplasma gondii provides promising targets for vaccination. Clin Exp Vaccine Res. 2020;9(2):146.
22. Khadem Mohammadi M, Ghaffari AD. Toxoplasma gondii (GRA10): A Closer Glance Into Immunogenic and Biochemical Characteristics Using In Silico Approach. Parasite Immunol. 2025;47(2):e70004.
23. Mohammadi MK, Dalir Ghaffari A. MIC13 of Toxoplasma gondii: Potential Gene for Vaccine Candidate—An In Silico Approach. J Parasitol Res. 2025;2025:3114690.
24. Zaki L, Ghaffarifar F, Sharifi Z, Horton J. Design and synthesis of RNA vaccines encoding SAG1 antigen of Toxoplasma gondii and evaluation of immunogenicity and its protective efficacy against acute toxoplasmosis in BALB/c mice. Vaccine. 2026;88:128785.
25. Walsh C. Posttranslational modification of proteins: expanding nature's inventory: Roberts and Company Publishers; 2006.
26. Lee T-Y, Hsu JB-K, Chang W-C, et al. A comprehensive resource for integrating and displaying protein post-translational mod-ifications. BMC Res Notes. 2009;2:111.
27. Hansson M, Nygren PA, Stah S. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem. 2000;32(2):95-107.
28. Rock KL, Reits E, Neefjes J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 2016; 37(11):724-37.
29. Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22(12):751-64.
30. Yadav G, Rao R, Raj U, Varadwaj PK. Computational modeling and analysis of prominent T-cell epitopes for assisting in designing vaccine of ZIKA virus. J Appl Pharm Sci. 2017;7(8):116-22.
31. Shaddel M, Ebrahimi M, Tabandeh MR. Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii. J Parasit Dis. 2018;42(2):269-76.
32. Chivian D, Kim DE, Malmström L, et al. Prediction of CASP6 structures using automated Robetta protocols. Proteins. 2005; 61 Suppl 7:157-166.
33. Zhang W, Wen H, Li J, et al. Immunology and immunodiagnosis of cystic echinococcosis: an update. Clin Dev Immunol. 2012;2012: 101895.
Files
IssueVol 21 No 3 (2026) QRcode
SectionOriginal Article(s)
Keywords
In silico analysis; E. granulosus Adenylate kinase 8 Vaccine candidate
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Bahadori Mazidi B, Fasehi Z, Abdollahi H, Naderizadeh M, Najafi A, Ghiabi S, Asghari A, Fathollahzadeh M, Majidiani H, Shabani L. Exploring Adenylate Kinase 8 (ADK8) of Echinococcus granulosus as a Novel Immunogen Against Cystic Echinococcosis: A Computational Perspective. Iran J Parasitol. 2026;21(3):335-347.